ArticleFEBS open bio2026
Importin 7 mediates the nuclear import of HIV-1 integrase via a specific interacting interface.
Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HIV-1 integrase (IN) must cross the nuclear envelope to access the host genome and catalyze viral DNA integration, a process that requires active nuclear import. Although recent work has established that the primary pathway for HIV-1 nuclear entry involves transport of the intact capsid, complementary mechanisms may enable the nuclear import of individual viral components through the host karyopherins. Among the host nuclear import factors implicated in this process, importin 7 (Imp7) has emerged as a strong candidate for IN, yet its precise role and the molecular basis of its interaction with IN have remained unclear. Here, we demonstrate that Imp7 acts as a critical mediator of IN nuclear import. Using hydrogen-deuterium exchange and cross-linking mass spectrometry, we map the interaction interface and identify the core domain of Imp7 as the primary IN binding site. Affinity measurements reveal high-affinity binding between IN and Imp7, while mutations within the C-terminal nuclear localization signal of IN significantly weaken this interaction. Consistent with these findings, knockdown of endogenous Imp7 in HEK293T cells leads to cytoplasmic accumulation of IN, confirming its essential role in nuclear import. Together, these results establish a direct, high-affinity interaction between IN and Imp7, define their molecular interface, and position Imp7 as a key nuclear import receptor for HIV-1 IN. This work provides detailed molecular insight into a critical host-virus interaction during early HIV-1 replication and highlights the Imp7-IN interface as a promising target for complementary therapeutic intervention aimed at disrupting integrase nuclear import.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.